The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
Applying Commission Policy To Determine On A Case-By-Case Basis Whether Particular Advertising Formats Such As Product Placements Are Deceptive
Letter To Commercial Alert Applying Commission Policy To Determine On A Case-By-Case Basis Whether Particular Advertising Formats Such As Product Placements Are Deceptive
20050533: Electro-Motive Diesel, Inc.; General Motors Corporation
0502006 Informal Interpretation
0502004 Informal Interpretation
0502005 Informal Interpretation
Granting of Request for Early Termination of the Waiting Period Under the Premerger Notification Rules
Genzyme Corporation and Ilex Oncology, Inc., In the Matter of
A consent order allowed Genzyme’s acquisition of ILEX Oncology, Inc., but requires the companies to divest certain assets in the market for solid organ transplant acute therapy drugs. Specifically, Genzyme is required to divest all contractual rights related to ILEX’s Campath®, an immunosuppressant antibody used in solid organ transplants to Schering AG.